- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Nucleic acid therapeutics as differentiation agents for myeloid leukemias ; day:29 ; month:2 ; year:2024 ; pages:1-14
Leukemia ; (29.2.2024), 1-14
- Urheber
-
Kovecses, Olivia
Mercier, François E.
McKeague, Maureen
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41375-024-02191-0
- URN
-
urn:nbn:de:101:1-2405070917024.029887166225
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kovecses, Olivia
- Mercier, François E.
- McKeague, Maureen
- SpringerLink (Online service)
Ähnliche Objekte (12)
Molecular MRD Assessment in Acute Myeloid Leukemias
Clinical and molecular characteristics of extramedullary acute myeloid leukemias
Leukemias
Catechol‐Siderophore Mimics Convey Nucleic Acid Therapeutics into Bacteria
Catechol‐Siderophore Mimics Convey Nucleic Acid Therapeutics into Bacteria
Modified nucleic acids: replication, evolution, and next-generation therapeutics
Unlocking the Potential of Chemically Modified Nucleic Acid Therapeutics
KMT2D Deficiency Promotes Myeloid Leukemias which Is Vulnerable to Ribosome Biogenesis Inhibition
STK3 is a therapeutic target for a subset of acute myeloid leukemias
Oral delivery of stabilized lipid nanoparticles for nucleic acid therapeutics
The significance of microRNAs for the development of pediatric acute myeloid leukemias
Role of Cytogenetics and Fluorescence In Situ Hybridization in the Laboratory Workup of Acute Myeloid Leukemias
Molecular MRD Assessment in Acute Myeloid Leukemias
Clinical and molecular characteristics of extramedullary acute myeloid leukemias
Leukemias
Catechol‐Siderophore Mimics Convey Nucleic Acid Therapeutics into Bacteria
Catechol‐Siderophore Mimics Convey Nucleic Acid Therapeutics into Bacteria
Modified nucleic acids: replication, evolution, and next-generation therapeutics
Unlocking the Potential of Chemically Modified Nucleic Acid Therapeutics
KMT2D Deficiency Promotes Myeloid Leukemias which Is Vulnerable to Ribosome Biogenesis Inhibition
STK3 is a therapeutic target for a subset of acute myeloid leukemias
Oral delivery of stabilized lipid nanoparticles for nucleic acid therapeutics
The significance of microRNAs for the development of pediatric acute myeloid leukemias
Role of Cytogenetics and Fluorescence In Situ Hybridization in the Laboratory Workup of Acute Myeloid Leukemias
Molecular MRD Assessment in Acute Myeloid Leukemias
Clinical and molecular characteristics of extramedullary acute myeloid leukemias
Leukemias
Catechol‐Siderophore Mimics Convey Nucleic Acid Therapeutics into Bacteria
Catechol‐Siderophore Mimics Convey Nucleic Acid Therapeutics into Bacteria
Modified nucleic acids: replication, evolution, and next-generation therapeutics
Unlocking the Potential of Chemically Modified Nucleic Acid Therapeutics
KMT2D Deficiency Promotes Myeloid Leukemias which Is Vulnerable to Ribosome Biogenesis Inhibition
STK3 is a therapeutic target for a subset of acute myeloid leukemias
Oral delivery of stabilized lipid nanoparticles for nucleic acid therapeutics
The significance of microRNAs for the development of pediatric acute myeloid leukemias